Adaptive Biotechnologies ADPT Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $70.5M+47.1% | $47.92M-26.3% | $65.06M-27.7% | $90.03M-35.3% | ||
| $156.49M-10.3% | $174.37M-38.0% | $281.34M-31.1% | $408.17M+90.7% | ||
| $2.69M-7.2% | $2.9M-1.2% | $2.93M+22.3% | $2.4M+12.2% | ||
| $50.37M+20.7% | $41.73M+9.9% | $37.97M-5.2% | $40.06M+130% | ||
| $9.82M+16.4% | $8.44M-41.6% | $14.45M0.0% | $14.45M-25.0% | ||
| $13.02M+15.4% | $11.29M-0.7% | $11.37M+20.4% | $9.44M-27.5% | ||
| $300.19M+5.8% | $283.75M-30.8% | $410.19M-27.0% | $562.15M+39.6% | ||
| $34.11M-29.8% | $48.62M-28.7% | $68.23M-18.2% | $83.45M-2.1% | ||
| $40.62M-11.3% | $45.77M-12.1% | $52.1M-35.5% | $80.76M-7.9% | ||
| $118.97M0.0% | $118.97M0.0% | $118.97M0.0% | $118.97M0.0% | ||
| $1.73M-49.6% | $3.43M-33.2% | $5.13M-24.9% | $6.83M-19.9% | ||
| $1.21M-47.2% | $2.29M-36.3% | $3.59M+74.0% | $2.06M+136% | ||
| $13.23M-60.7% | $33.66M— | —— | —— | ||
| $512.74M-4.9% | $539.38M-18.4% | $661.13M-22.8% | $856.62M-7.2% | ||
| $6.47M-11.0% | $7.27M-5.9% | $7.72M-4.5% | $8.08M+144% | ||
| $16.99M+7.3% | $15.84M+15.7% | $13.69M-14.1% | $15.94M+1.9% | ||
| $45.19M-18.8% | $55.69M+14.5% | $48.63M-24.2% | $64.12M-20.3% | ||
| $4.64M+437% | $865K— | —— | —— | ||
| $8.92M-12.9% | $10.24M+9.1% | $9.38M+1.7% | $9.23M+82.6% | ||
| $1.01M-96.3% | $27.26M-39.2% | $44.79M-23.6% | $58.6M-40.7% | ||
| $89.92M-8.3% | $98.05M+11.4% | $88.02M-19.8% | $109.79M-3.5% | ||
| $126.57M-4.4% | $132.41M+1.3% | $130.66M+4.2% | $125.36M— | ||
| $70.23M-11.3% | $79.15M-11.5% | $89.39M-9.5% | $98.77M-7.4% | ||
| $79.15M-11.5% | $89.39M-9.5% | $98.77M-8.5% | $108M-3.3% | ||
| $20K0.0% | $20K— | —— | —— | ||
| $287.74M-14.6% | $336.89M-4.5% | $352.86M-10.1% | $392.52M+23.0% | ||
| $15K+7.1% | $14K0.0% | $14K0.0% | $14K0.0% | ||
| $1.58B+5.0% | $1.51B+3.7% | $1.45B+4.7% | $1.39B+4.8% | ||
| -$1.36B-4.6% | -$1.3B-13.9% | -$1.14B-24.5% | -$919.08M-27.8% | ||
| $253K+52.4% | $166K-22.8% | $215K+105% | -$4.12M-262% | ||
| $6.21M+2,871% | -$224K-85.1% | -$121K-80.6% | -$67K-161% | ||
| $218.79M+7.9% | $202.71M-34.3% | $308.4M-33.6% | $464.17M-23.2% | ||
| $512.74M-4.9% | $539.38M-18.4% | $661.13M-22.8% | $856.62M-7.2% | ||
| $156.49M-10.3% | $174.37M-38.0% | $281.34M-31.1% | $408.17M+90.7% | ||
| $1.21M-47.2% | $2.29M-36.3% | $3.59M+74.0% | $2.06M+136% | ||
| $40.62M-11.3% | $45.77M-12.1% | $52.1M-35.5% | $80.76M-7.9% | ||
| $13.23M-60.7% | $33.66M— | —— | —— | ||
| $1.73M-49.6% | $3.43M-33.2% | $5.13M-24.9% | $6.83M-19.9% | ||
| $40.62M-11.3% | $45.77M-12.1% | $52.1M-35.5% | $80.76M-7.9% | ||
| $1.21M-47.2% | $2.29M-36.3% | $3.59M+74.0% | $2.06M+136% | ||
| $40.62M-11.3% | $45.77M-12.1% | $52.1M-35.5% | $80.76M-7.9% | ||
| $1.21M-47.2% | $2.29M-36.3% | $3.59M+74.0% | $2.06M+136% | ||
| $16.99M+7.3% | $15.84M+15.7% | $13.69M-14.1% | $15.94M+1.9% | ||
| $1.01M-96.3% | $27.26M-39.2% | $44.79M-23.6% | $58.6M-40.7% | ||
| $7.7M-5.6% | $8.16M-5.1% | $8.6M-30.8% | $12.42M+33.0% | ||
| $7.7M-5.6% | $8.16M-5.1% | $8.6M-30.8% | $12.42M+33.0% | ||
| $16.99M+7.3% | $15.84M+15.7% | $13.69M-14.1% | $15.94M+1.9% | ||
| $1.01M-96.3% | $27.26M-39.2% | $44.79M-23.6% | $58.6M-40.7% | ||
| $1.01M-96.3% | $27.26M-39.2% | $44.79M-23.6% | $58.6M-40.7% | ||
| $210.36M-5.5% | $222.67M-2.9% | $229.43M-1.7% | $233.36M+109% | ||
| $15K+7.1% | $14K0.0% | $14K0.0% | $14K0.0% | ||
| $6.21M+2,871% | -$224K-85.1% | -$121K-80.6% | -$67K-161% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Adaptive Biotechnologies's total assets?
- Adaptive Biotechnologies (ADPT) holds $505.9M in total assets, down 1.0% year over year.
- How much debt does Adaptive Biotechnologies have?
- Adaptive Biotechnologies carries $208.2M in total debt against $216.3M of shareholders' equity, a debt-to-equity ratio of 0.96.
- How much cash does Adaptive Biotechnologies have?
- Adaptive Biotechnologies holds $77.6M in cash and equivalents.
- Can Adaptive Biotechnologies cover its short-term obligations?
- Its current ratio is 3.35 — current assets exceed current liabilities.
- Where does Adaptive Biotechnologies's balance sheet data come from?
- Every line is extracted from Adaptive Biotechnologies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
